The ability of cytotoxic CD4+ T cells (CD4-CTLs) to directly kill MHCII+ targets expressing cognate Ag in vitro has raised significant interest among viral and tumor immunologists alike (7, 8). This evidence concerns the gene CD4 and neoplasm.